Cabot’s 5 Top Stocks to buy in 2016

By hearring, March 29, 2016

Any insight on the the stocks Cabot’s touting.
Ligand Pharmaceuticals (LGND)
Solar Edge (SEDG)
Universal Display

Thank you…Karen

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

5
Share your thoughts...

avatar
3 Comment threads
2 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
3 Comment authors
hearringTravis Johnson, Stock GumshoeSoGiAm Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

SoGiAm
Member
๐Ÿ‘11363

$LGND-Karen, this is probably the best and most recent article by Travis on Ligand Pharmaceuticals: http://www.stockgumshoe.com/2016/01/irregulars-annual-review/

SoGiAm
Member
๐Ÿ‘11363

$LGND also covered in this February article: http://www.stockgumshoe.com/2016/02/february-idea-of-the-month/ Best2You-Ben

Add a Topic
3413
Travis Johnson, Stock Gumshoe
Admin
๐Ÿ‘12309

I haven’t looked at Universal Display lately, or Solar Edge at all, but do, as sogiam notes, own Ligand and find it an appealing but fairly high risk holding. Not as risky as junior biotechs awaiting trial results, but riskier than the “royalties” idea might convey because they are extremely reliant on two royalties (Kyprolis and Promacta) for the lion’s share of income. There is potential for high reward as well, of course, and that depends on some of their other top half-dozen drugs in development getting approved and selling well enough to generate substantial royalties… and their cost base… Read more ยป

Add a Topic
996